medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number S1

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (S1)

Clinical manifestations of COVID-19

Romo DKJ, Saucedo REG, Hinojosa MS, Mercado RJY, Uc RJE, Ochoa GE, Madrid MW, Olmedo JA, Del Razo RR, García CER, Velázquez SJR, Avilés RAB, Lechuga TI, Gochicoa RLG, Guzmán VCR, Corona VCA, Dionicio AAR, Monsiváis OAC, Munive BL, Rojas AL, Padilla BT

Language: Spanish
References: 129
Page: 10-32
PDF size: 502.99 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020; 395 (10223): 497-506. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930183-5

  2. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M et al. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc. 2020; 19-21.

  3. Guan W, Ni Z, Hu YYY, Liang W, Ou C, He J et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med [Internet]. 2020; 382 (18): 1708-1720. Available from: https://www.nejm.org/doi/pdf/10.1056/nejmoa2002032

  4. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020; 382: 1370-1371.

  5. Jiehao C, Jing X, Daojiong L, Lei X, Zhenghai Q, Yuehua Z et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis [Internet]. 2020; 71 (6): 1547-1551. Available from: https://watermark.silverchair.com/ciaa198.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAmswggJnBgkqhkiG9w0BBwagggJYMIICVAIBADCCAk0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM1i3M7PHkC6dAzL12AgEQgIICHtn40-AX0dBKm8bw1-kHsLT7OPT9cbRqoEDGRGxEbQOEYp1

  6. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA [Internet]. 2020; 323 (13): 1313-1314. Available from: https://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jama/articlepdf/2761659/jama_wei_2020_ld_200011.pdf&hl=es&sa=T&oi=ucasa&ct=ufr&ei=1hyjXtTqHdS5ygTUiqrACQ&scisig=AAGBfm10yWRCsrPZldbfD9MqncsOooAIgA

  7. Saavedra-Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en el consenso de expertos e informadas en la evidencia. Asociación Colombiana de Infectología. Infectio [Internet]. 2020; 24 (3): 1-153. Disponible en: https://www.revistainfectio.org/index.php/infectio/article/view/851/946

  8. Tiago H, de Souza JAN. Clinical manifestations of children with COVID-19: a systematic review Tiago H. de Souza. meRxiv [Internet]. 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.04.01.20049833v2.full.pdf

  9. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res [Internet]. 2020; 7 (1): 11. Available from: https://mmrjournal.biomedcentral.com/track/pdf/10.1186/s40779-020-00240-0

  10. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z. Epidemiology of COVID-19 Among children in China. Pediatrics [Internet]. 2020; 145: e20200702. Available from: https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.1.full.pdf

  11. Secretaría de Salud Federal. Aviso epidemiológico. Enfermedad COVID-19 por SARS-CoV-2 [Internet]. 2020. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/541794/AE_Enfermedad_COVID-19_SARS-CoV-2_2020.03.17.pdf

  12. Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv [Internet]. 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20041889v1.full.pdf

  13. Mao L, Wang M, Chen S, He Q, Chang J, Hong C et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv [Internet]. 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.02.22.20026500v1.full.pdf+html

  14. World Health Organization. Global surveillance for human infection with coronavirus disease (COVID-19) [Internet]. Interim Guidance. 2020. pp. 27-29. Available from: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov)

  15. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol [Internet]. 2020; 55 (5): 1169-1174. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ppul.24718

  16. Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH et al. Chest radiographic and ct findings of the 2019 novel coronavirus disease (Covid-19): analysis of nine patients treated in Korea. Korean J Radiol [Internet]. 2020; 21 (4): 498-504. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082662/pdf/kjr-21-494.pdf

  17. Dirección General de Epidemiología. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorios de COVID-19 [Internet]. Secretaría de Salud Gobierno de México. 2020. pp. 1-58. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/537944/Lineamiento_COVID-19_2020.02.27.pdf

  18. Calvo Rey M, García-López Hortelano J, Tomás Ramos F, Baquero Navarro M. Documento de manejo clínico del paciente pediátrico con infección por SARS-CoV-2. Extracto del Documento de Manejo Clínico del Ministerio de Sanidad Redactores pertenecientes a la Asociación Española de Pediatría (AEP): Sociedad Española de Infectología Pediátrica [Internet]. 2020. pp. 1-17. Disponible en: https://www.analesdepediatria.org/contenidos/pdf/Recomendaciones_pediatricas_Covid1.pdf

  19. World Health Organization (WHO). Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected

  20. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020; 21 (2): e52-e106.

  21. Calvo C, García López-Hortelano M, De Carlos Vicente JC, Vázquez Martínez JL y Grupo de trabajo de la Asociación Española de Pediatría. Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). An Pediatr (Barc) [Internet]. 2020; 92 (4): 241.e1-241.e11. Disponible en: https://www.analesdepediatria.org/es-pdf-S169540332030076X

  22. Fang Y, Han Y, Feng Z, Sun L, Ren X, Wang H et al. A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults. J Med Virol. 2020; 10.1002/jmv.25835.

  23. Yang P, Liu P, Li D, Zhao D. Corona virus disease 2019, a growing threat to children? J Infect [Internet]. 2020; 80 (6): 671-693. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125808/pdf/main.pdf

  24. Al-Tawfiq JA, Memish ZA. Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR: reflecting on experience from MERS-CoV. J Hosp Infect [Internet]. 2020; 105 (2): 154-155. Available from: https://www.journalofhospitalinfection.com/action/showPdf?pii=S0195-6701%2820%2930100-6

  25. Brodin P. Why is COVID-19 so mild in children? Acta Paediatr. 2020; 109 (6): 1082-1083.

  26. Yonker LM, Shen K, Kinane TB. Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection. Pediatr Pulmonol [Internet]. 2020; 55: 1085-1086. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24748

  27. Choi SH, Kim HW, Kang JM, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Clin Exp Pediatr [Internet]. 2020; 63 (4): 125-132. Available from: https://www.e-cep.org/upload/pdf/cep-2020-00535.pdf

  28. Hagmann SHF. COVID-19 in children: More than meets the eye. Travel Med Infect Dis [Internet]. 2020; 34: 101649. Available from: https://reader.elsevier.com/reader/sd/pii/S1477893920301174?token=02C6232597CD9CEBEE34B8C157D80B678BDEA668612C0C634C2715A817AAD080B09CB1491E1B9BEF99F72872F4A5E1A1

  29. Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C. Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatr Pulmonol. 2020; 55 (6): 1430-1432.

  30. She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol [Internet]. 2020; 92 (7): 747-754. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25807

  31. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020; 20 (6):C 689-696.

  32. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (14): 422-426.

  33. Kolifarhood G, Aghaali M, Mozafar Saadati H et al. Epidemiological and clinical aspects of COVID-19; a narrative review. Arch Acad Emerg Med [Internet]. 2020; 8 (1): e41. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117787/pdf/aaem-8-e41.pdf

  34. Lu X, Zhang L, Du H et al. SARS-CoV-2 infection in children. N Engl J Med [Internet]. 2020; 382 (17): 1663-1665. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMc2005073

  35. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol [Internet]. 2020; 277 (8): 2251-2261. Available from: https://link.springer.com/content/pdf/10.1007/s00405-020-05965-1.pdf

  36. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/

  37. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020; 395 (10223): 507-513. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930211-7

  38. Li SR, Tang ZJ, Li ZH, Liu X. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. Eur J Clin Microbiol Infect Dis [Internet]. 2020; 39 (6): 1021-1026. Available from: https://www.unboundmedicine.com/medline/citation/32285293/Searching_therapeutic_strategy_of_new_coronavirus_pneumonia_from_angiotensin_converting_enzyme_2: _the_target_of_COVID_19_and_SARS_CoV_

  39. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol [Internet]. 2020; 92 (6): 568-576. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25748

  40. Rivero KN, Araneda KP, Astorga KE, Améstica KM, Cruces P. Síndrome de distrés respiratorio agudo en pediatría. Neumol Pediatr. 2016; 11 (4): 168-174.

  41. Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC et al. Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection. Ann Acad Med Singap. 2020; 49 (3): 108-118.

  42. Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol [Internet]. 2020; 35 (5): 744-748. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15047

  43. D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol [Internet]. 2020; 18 (8): 1663-1672. Available from: https://www.cghjournal.org/article/S1542-3565(20)30481-X/pdf

  44. Gao QY, Chen YX, Fang JY. 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis [Internet]. 2020; 21 (3): 125-126. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12851?casa_token=QDEP-vw1IBIAAAAA:bYzUxaVnF52Jh-pWrXtT3Lriw5iwfcCD-RvVwnbmR594ugg83VEM3IyMVmx8Hbv0O3CEH2ruv-U79As

  45. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology [Internet]. 2020; 159 (1): 81-95. Available from: https://doi.org/10.1053/j.gastro.2020.03.065

  46. Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc [Internet]. 2020; 83 (6): 521-523. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176263/pdf/ca9-publish-ahead-of-print-10.1097.jcma.0000000000000319.pdf

  47. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606.

  48. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-1069.

  49. Riddle MS, Dupont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016; 111 (5): 602-622.

  50. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology [Internet]. 2020; 158 (6): 1831-1833.e3. Available from: https://www.gastrojournal.org/article/S0016-5085(20)30282-1/pdf?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F

  51. Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S et al. SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Am J Gastroenterol [Internet]. 2020; 115 (6): 942-946. Available from: https://journals.lww.com/ajg/Documents/COVID19_Carvalho_et_al_AJG_Preproof.pdf

  52. Li LY, Wu W, Chen S, Gu JW, Li XL, Song HJ et al. Digestive system involvement of novel coronavirus infection: Prevention and control infection from a gastroenterology perspective. J Dig Dis [Internet]. 2020; 21 (4): 199-204. Available from: onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12862?casa_token=8CDzcyGwpeYAAAAA:TNgtBh4GDEhvILZpm8YD_2M9PxunschMsUR781B6hsggyoWCDxHU-dtxSAsL402yI_C3i9U61Q9kx5I

  53. Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology [Internet]. 2020; 158 (6): 1518-1519. Available from: https://www.gastrojournal.org/article/S0016-5085(20)30281-X/pdf

  54. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med [Internet]. 2020; 382 (16): 1564-1567. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMc2004973

  55. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science [Internet]. 2020; 368 (6490): 489-493. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164387/pdf/abb3221.pdf

  56. Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004; 39 (2): 302-310.

  57. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int [Internet]. 2020; 40 (9): 2095-2103. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14455?casa_token=3lXSe_TZRCUAAAAA:oQPbgM4m4M6lkUd8a-SjtUNu0KG25hbb_luey8sF4XGpHUCYcN7qei3QpA_GLP5c2z0LePzSOJNh5j8

  58. Chai X, Hu L, Zhang Y et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-ncov infection. bioRxiv [Internet]. 2020. Available from: https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1.full.pdf

  59. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. Kidney Int [Internet]. 2020; 97: 829-838. Available from: https://www.kidney-international.org/article/S0085-2538(20)30255-6/pdf

  60. Mou H, Raj VS, van Kuppeveld FJM, Rottier PJM, Haagmans BL, Bosch BJ. The receptor binding domain of the new middle east respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013; 87 (16): 9379-9383.

  61. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med [Internet]. 2020; 382 (17): 1653-1659. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121452/pdf/NEJMsr2005760.pdf

  62. Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020; 92 (6): 595-601.

  63. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020; 97 (5): 824-828.

  64. Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020; 144 (5): 213-221.

  65. Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA. Collapsing glomerulopathy in a patient with COVID-19. Kidney Int Rep [Internet]. 2020; 5 (6): 935-939. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142700/

  66. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52 (6): 1193-1194.

  67. Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013; 9 (5): 255-265.

  68. Vanmassenhove J, Kielstein J, Jörres A, Biesen WV. Management of patients at risk of acute kidney injury. Lancet. 2017; 389 (10084): 2139-2151.

  69. Li Z, Wu M, Yao J, Guo J, Liao X, Song S et al. Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 2020.

  70. Ronco C, Reis T, De Rosa S. Coronavirus epidemic and extracorporeal therapies in intensive care: si vis pacem para bellum. Blood Purif [Internet]. 2020; 49 (3): 255-258. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179535/pdf/bpu-0049-0001.pdf

  71. Sociedad Chilena de Medicina. Recomendaciones para el uso de terapias farmacológicas contra COVID-19 [Internet]. 2020. Disponible en: http://www.colegiomedico.cl/wp-content/uploads/2020/03/Consolidacion-Terapia-COVID-19-FINAL.pdf.pdf.pdf.pdf

  72. Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020; 35 (5): 737-741.

  73. Ikizler TA. COVID-19 and dialysis units: what do we know now and what should we do? Am J Kidney Dis [Internet]. 2020; 76 (1): 1-3. Available from: https://reader.elsevier.com/reader/sd/pii/S0272638620306089?token=E5F4A8BE5C5F6B85B9C2C2133192DC96FCF7D36C10E5AEB67812FA050D6CCF4EBCE4BAD34B79B6BCA3E7A253FB1CF011

  74. Leading European Nephrology. COVID-19 news and information [Internet]. 2020. Available from: https://www.era-edta.org/en/covid-19-news-and-information/

  75. American Society of Transplantation. Coronavirus disease 2019 (COVID-19): Frecuently asked questions from transplant candidates and recipients [Internet]. 2020. Available from: https://www.myast.org/coronavirus-disease-2019-covid-19-frequently-asked-questions-transplant-candidates-and-recipients#

  76. Zheng Y, Lai W. Dermatology staff participate in fight against Covid-19 in China. J Eur Acad Dermatol Venereol [Internet]. 2020; 34 (5): e210-e211. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16390?casa_token=nyINb2hVTm8AAAAA: GxAxV6wGLvOpUOHnK-vaHKsSONE4DYrAn0KqQCdKzBiSc5RQ4CiM3KQf0BoovAyY8v1eDZGjVddsxcY

  77. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol [Internet]. 2020; 34 (5): e212-e213. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16387

  78. Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol [Internet]. 2020; 82 (5): e177. Available from: https://reader.elsevier.com/reader/sd/pii/S0190962220304540?token=D1C915CCD23BAB4D5191A289CF1953691F2A8B36B6D25C327DDD9D140BD5D7ED9209CF5F432EE32D1AC00C46EC68DFE6

  79. Hoenig LJ, Pereira FA. Rash as a clinical manifestation of COVID-19 photographs of a patient. Clin Dermatol [Internet]. 2020. Disponible en: https://doi.org/10.1016/j.clindermatol.2020.04.001

  80. Mazzotta F, Troccoli T. Acute acro-ischemia in the child at the time of COVID-19. Eur J Pediat Dermatol [Internet]. 2020; 30 (2): 71-74.

  81. Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol [Internet]. 2020; 83 (2): 700. Available from: https://reader.elsevier.com/reader/sd/pii/S0190962220305582?token=26A7BF1E096BE97BC24613ED38B34F5A07515905FB57EF7E36DB88C0EC03DCC91FBC106A772ECF3B9EF5EE6C2841BCF9

  82. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi [Internet]. 2020; 41 (0): E006. Available from: http://rs.yiigle.com/yufabiao/1186612.htm

  83. Le Syndicat National des Dermatologues-Vénéréologues (SNDV) alerte sur les manifestations cutanées du COVID 19 [Internet]. Communiqué de presse. Le 6 avril 2020. Available from: https://www.syndicatdermatos.org/wp-content/uploads/2020/04/cp-covid-peau-6-avril.pdf

  84. Academia Española de Dermatología y Venereología. La AEDV colabora con el estudio COVID-Piel que se acaba de poner en marcha en España [Internet]. 2020. Disponible en: https://aedv.es/la-aedv-colabora-con-el-estudio-covid-piel-que-se-acaba-de-poner-en-marcha-en-espana/

  85. Han H, Yang L, Liu R, Liu F, Wu KL, Li J et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [Internet]. Clin Chem Lab Med. 2020; 58 (7): 1116-1120. Available from: https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0188/article-10.1515-cclm-2020-0188.xml?language=en

  86. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost [Internet]. 2020; 18 (7): 1752-1755. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14828

  87. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost [Internet]. 2020; 18 (5): 1023-1026. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14810

  88. Go YY, Kim Y, Cheon S, Nam S, Ku B, Kim M et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Hypothesis [Internet]. 2020; 395: 1517-1520. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930920-X

  89. Álvarez-Hernández LF, Herrera-Almanza L. Disseminated intravascular coagulation: Relevant aspects for the diagnosis. Med Interna Mex. 2018; 34 (5): 735-745.

  90. Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, ten Cate H, Thachil J et al. Supportive management strategies for disseminated intravascular coagulation: An international consensus. Thromb Haemost. 2016; 115 (5): 896-904.

  91. Connors J, States U, Levy J, States U. COVID-19 and its implications for thrombosis and anticoagulation COVID-19 and its implications for thrombosis and anticoagulation. Blood [Internet]. 2020; 135 (23): 2033-2040. Available from: https://watermark.silverchair.com/bloodbld2020006000c.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA5YwggOSBgkqhkiG9w0BBwagggODMIIDfwIBADCCA3gGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMldh6BiJ17AdXg5OnAgEQgIIDSQH3Uekf0--0Kqm1oviDuxBcdJ0P7WmvB0H

  92. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la respuesta inmune trombótica asociada a Covid-19 (RITAC) [Internet]. 2020. Disponible en: https://fundacionio.com/wp-content/uploads/2020/04/Si%CC%81ndrome-RITAC.pdf.pdf.pdf.pdf.pdf.pdf.pdf

  93. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev [Internet]. 2020; 19 (6): 102537. Available from: https://www.researchgate.net/publication/340266188_Interleukin-6_Use_in_COVID-19_Pneumonia_Related_Macrophage_Activation_Syndrome

  94. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science [Internet]. 2020; 368 (6490): 473-474. Available from: https://science.sciencemag.org/content/368/6490/473/tab-pdf

  95. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la respuesta inmune trombótica asociada a Covid-19 (RITAC). CorSalud. 2020; 12 (1): 60-63.

  96. Zhang Y, Xiao M, Zhang S et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med [Internet]. 2020; 382 (17): e38. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMc2007575

  97. Newall F, Branchford B, Male C. Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J Thromb Haemost. 2018; 16 (2): 196-208.

  98. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci [Internet]. 2020; 11 (7): 995-998. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094171/

  99. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92 (6): 552-555.

  100. Turtle L. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. J Med Virol [Internet]. 2020; 92 (7): 705-706. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25828

  101. Ezpeleta D, García Azorín D. Manual COVID-19 para el neurólogo general [Internet]. San Sebastián de los Reyes, Madrid: Sociedad Española de Neurología; 2020. Disponible en: http://www.sen.es/attachments/article/2677/Manual_neuroCOVID-19_SEN.pdf

  102. Dugue R, Cay-Martínez KC, Thakur KT et al. Neurologic manifestations in an infant with COVID-19. Neurology [Internet]. 2020; 94 (24): 1100-1102. Available from: https://n.neurology.org/content/neurology/early/2020/05/18/WNL.0000000000009653.full.pdf

  103. Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol [Internet]. 2020; 5 (2): 146-151. Available from: https://svn.bmj.com/content/svnbmj/early/2020/05/07/svn-2020-000382.full.pdf

  104. Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020; 8 (4): 420-422. Available from: https://reader.elsevier.com/reader/sd/pii/S221326002030076X?token=85A1B05DA737FFB7653E0FDF921C87960156C5A63A6C319DCCFCBE571983A846E524A235EA8F7E7849B9D7A8A2207BFE

  105. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020; 80 (4): 401-416.

  106. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77 (6): 683-690.

  107. Valderrama EV, Humbert K, Lord A, Frontera J, Yaghi S. Severe acute respiratory syndrome coronavirus 2 infection and ischemic stroke. Stroke [Internet]. 2020; 51 (7): e124-e127. Available from: https://doi.org/10.1161/STROKEAHA.120.030153

  108. McAbee GN, Brosgol Y, Pavlakis S, Agha R, Gaffoor M. Encephalitis associated with COVID-19 infection in an 11 year-old child. Pediatric Neurology. Brooklyn, NY: Elsevier Inc.; 2020.

  109. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis [Internet]. 2020; 94: 55-58. Available from: https://reader.elsevier.com/reader/sd/pii/S1201971220301958?token=760D84E8F46C05B842665DCBEF1567F3422C8FA0A970B6187A8D88778E7971007E451A6E2C93D0CBB7484F73CE96403A

  110. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology [Internet]. 2020; 296 (2): E119-E120. Available from: https://pubs.rsna.org/doi/pdf/10.1148/radiol.2020201187

  111. Sociedad Colombiana de Pediatría. Complicaciones neurológicas por COVID-19, en niños de Colombia [Internet]. 2020. Disponible en: https://scp.com.co/wp-content/uploads/2020/04/comunicado-SCP-ASCONI-COVID19.pdf

  112. Finsterer J, Stollberger C. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients. J Med Virol [Internet]. 2020; 10.1002/jmv.25903. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25903

  113. Cheng JL, Huang C, Zhang GJ, Liu DW, Li P, Lu CY et al. Epidemiological characteristics of novel coronavirus pneumonia in Henan. Chinese J Tuberc Respir Dis [Internet]. 2020; 1 (0): E027. Available from: http://rs.yiigle.com/yufabiao/1183298.htm

  114. Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis [Internet]. 2020; 26 (7): 1618-1620. Available from: https://wwwnc.cdc.gov/eid/article/26/7/20-0445_article

  115. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol [Internet]. 2020; 19 (5): 383-384. Available from: https://www.thelancet.com/action/showPdf?pii=S1474-4422%2820%2930109-5

  116. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC Basic Transl Sci [Internet]. 2020; 5 (5): 518-536. Available from: https://reader.elsevier.com/reader/sd/pii/S2452302X20301571?token=749958327A5BD0A6700579CE08B5F80691AA4E668BB489B346FECEBEE64C7D9DA09B7A2D9123C8550A5A4A6A36266B38

  117. Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol [Internet]. 2020; 76 (5): 533-546. Available from: https://www.onlinejacc.org/content/accj/early/2020/06/08/j.jacc.2020.06.007.full.pdf

  118. Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail [Internet]. 2020; 22 (5): 911-915. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1828

  119. Ho JS, Tambyah PA, Ho AF, Chan MY, Sia CH. Effect of coronavirus infection on the human heart: A scoping review. Eur J Prev Cardiol [Internet]. 2020; 27 (11): 1136-1148. Available from: https://journals.sagepub.com/doi/pdf/10.1177/2047487320925965

  120. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J [Internet]. 2020; 41 (19): 1798-1800. DOI: 10.1093/eurheartj/ehaa231

  121. Cosyns B, Lochy S, Luchian ML, Gimelli A, Pontone G, Allard SD et al. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients. Eur Heart J Cardiovasc Imaging. 2020; 21 (7): 709-714.

  122. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 45 (3): 230-232.

  123. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res [Internet]. 2020; 116 (10): C1666-1687. Available from: DOI: 10.1093/cvr/cvaa106

  124. Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr [Internet]. 2020; 179 (7): 1079-1087. Available from: https://link.springer.com/content/pdf/10.1007/s00431-020-03699-0.pdf

  125. Barker PCA, Lewin MB, Donofrio MT et al. Specific considerations for pediatric, fetal, and congenital heart disease patients and echocardiography service providers during the 2019 novel coronavirus outbreak: council on pediatric and congenital heart disease supplement to the statement of the american society of echocardiography: endorsed by the Society of Pediatric Echocardiography and the Fetal Heart Society. J Am Soc Echocardiogr [Internet]. 2020; 33 (6): 658-665. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144602/pdf/main.pdf

  126. Belhadjer Z, Méot M, Bajolle F et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation [Internet]. 2020; 10.1161/CIRCULATIONAHA.120.048360. Available from: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.048360

  127. Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA [Internet]. 2020; 324 (3): 294-296. Available from: https://jamanetwork.com/journals/jama/fullarticle/2767207

  128. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA [Internet]. 2020; 324 (3): 259-269. Available from: https://jamanetwork.com/journals/jama/fullarticle/2767209

  129. Son MBF. Pediatric inflammatory syndrome temporally related to covid-19. BMJ [Internet]. 2020; 369: m2123. Available from: https://www.bmj.com/content/bmj/369/bmj.m2123.full.pdf




2020     |     www.medigraphic.com